Potential Probiotic Characteristics and Safety Assessment of Lactobacillus rhamnosus SKG34 Isolated from Sumbawa Mare’s Milk
Microbiology and Biotechnology Letters · 28.03.2022 · 50 (1) · 51-62
DOI: 10.48022/mbl.2111.11007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology and Biotechnology Letters, erschienen am 28.03.2022. Verfasst von I Nengah Sujaya und 8 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
I Nengah Sujaya, Gede Ngurah Rsi Suwardana, Kazuyoshi Gotoh, I Wayan Sumardika, Komang Ayu Nocianitri, Ni Putu Sriwidyani, I Wayan Gede Artawan Eka Putra, Masakiyo Sakaguchi, and Ni Nengah Dwi Fatmawati. Microbiol. Biotechnol. Lett. 2022;50:51-62. https://doi.org/10.48022/mbl.2111.11007
Zitieren
APA
Sujaya, I. N., Suwardana, G. N. R., Gotoh, K., Sumardika, I. W., Nocianitri, K. A., Sriwidyani, N. P., Putra, I. W. G. A. E., Sakaguchi, M., & Fatmawati, N. N. D. (2022). Potential Probiotic Characteristics and Safety Assessment of Lactobacillus rhamnosus SKG34 Isolated from Sumbawa Mare’s Milk. Microbiology and Biotechnology Letters, 50(1), 51-62. https://doi.org/10.48022/mbl.2111.11007
Vancouver
Sujaya IN, Suwardana GNR, Gotoh K, Sumardika IW, Nocianitri KA, Sriwidyani NP, et al. Potential Probiotic Characteristics and Safety Assessment of Lactobacillus rhamnosus SKG34 Isolated from Sumbawa Mare’s Milk. Microbiology and Biotechnology Letters. 2022;50(1):51-62. doi:10.48022/mbl.2111.11007
BibTeX
@article{Sujaya2022,
author = {Sujaya, I Nengah and Suwardana, Gede Ngurah Rsi and Gotoh, Kazuyoshi and Sumardika, I Wayan and Nocianitri, Komang Ayu and Sriwidyani, Ni Putu and Putra, I Wayan Gede Artawan Eka and Sakaguchi, Masakiyo and Fatmawati, Ni Nengah Dwi},
title = {Potential Probiotic Characteristics and Safety Assessment of Lactobacillus rhamnosus SKG34 Isolated from Sumbawa Mare’s Milk},
journal = {Microbiology and Biotechnology Letters},
year = {2022},
volume = {50},
number = {1},
pages = {51--62},
doi = {10.48022/mbl.2111.11007}
}
EUVIMED